Increased CD62e+ Endothelial Microparticle Levels Predict Poor Outcome in Pulmonary Hypertension Patients

Elevated levels of circulating CD62e+ EMPs but not LMPs in PH patients prior to treatment are associated with adverse clinical events. Assessment of CD62e+ EMPs levels may represent a new tool for stratification of PH patients.